Mar 28, 2022
In this industry talk, Dr. Allyson Berent talks about "A Parent’s Journey Through Drug Development and Wearing Many Hats". Berent is the Chief Science Officer for the Foundation for Angelman Syndrome Therapeutics and the Chief Operating Officer for GeneTx Biotherapeutics, developing a novel antisense olignonucleotide...